Myeloproliferative Disease

Filter By:
03:09
Myeloproliferat​ive neoplasms are sometimes referred to as inflammatory conditions. Dr. Bart Scott from Seattle Cancer Care Alliance and Dr. David Snyder from City of Hope expand on exactly what this means and how treatment can affect these inflammatory symptoms caused by MPNs. Get email alerts | http://www.p... Subscr...
by:patientpower | 42 views
05:16
When discussing MPN treatments, transplant often is discussed. Terms like stem cell, autologous and bone marrow get thrown around, but what does it all mean? Dr. David Snyder from City of Hope and Dr. Bart Scott from Seattle Cancer Care Alliance differentiate between the types of transplant and expl...
by:patientpower | 81 views
02:24
In some cases, doctors recommend radiation to reduce the size of the spleen. What does that mean for the patient? What can they expect? Dr. Alison Moliterno from Johns Hopkins and Dr. Brady Stein from Northwestern Medicine give their opinions on how radiation to treat enlarged spleens may affect patients. Get email alerts | http://www.p......
by:patientpower | 102 views
03:27
Seattle Cancer Alliance's Dr. Bart Scott discusses the Oral Parity Act and why it’s important for patients, especially those with myelofibrosis, to get involved. He explains how the Oral Parity Act can have an affect on how insurance companies pay for chemotherapy. Get email alerts | http://www.p... Subscribe on YouTu...
by:patientpower | 195 views
26:46
Filmed at the US Focus on Myeloproliferat​ive Neoplasms and Myelodysplastic Syndromes 2014 meeting, this video discussion between Drs. Srdan Verstovsek, Ruben A. Mesa, Jason R. Gotlib, and Ramon V. Tiu outlines key learning points and summarizes take home messages from the presented content. This eng...
by:imedex | 232 views
02:12
Some people can be on Hydrea® (hydroxyurea) for an extended time period. But what are the long-term effects of this therapy? Dr. Bart Scott from Seattle Cancer Care Alliance discusses research for this treatment and the long-term safety of this medication. Get email alerts | http://www.p... Subscribe on YouTube |...
by:patientpower | 236 views
04:01
Is there a risk with suddenly stopping treatment that is working for you? Dr. David Snyder from City of Hope and Dr. Bart Scott from Seattle Cancer Care Alliance discuss the effects of discontinuing use of the JAK inhibitor, Jakafi®, and why tapering off of this medication is recommended. Get ema...
by:patientpower | 195 views
01:27
A common symptom of myeloproliferat​ive neoplasm (MPNs) is an enlarged spleen. So what causes an enlarged spleen in patients who have myelofibrosis, polycythemia vera or essential thrombocythemia? As part of our “Ask the Expert” series, Dr. Ross Levine from Memorial Sloan Kettering Cancer Center explains what is happening inside the bone marrow and ...
by:patientpower | 239 views
01:15
As part of our “Ask the Expert” series, Dr. Ross Levine from Memorial Sloan Kettering Cancer Center discusses chemical exposure as a potential cause of MPNs. Dr. Levine shares what researchers have learned about the Superfund site in Pennsylvania and Agent Orange. Get email alerts | http://www.p... Subscribe on YouTub...
by:patientpower | 181 views
02:55
Information about MPNs and JAK2 mutations abounds, including treatments that are appropriate for those with the mutation. But what if you’re JAK2 negative? Dr. Brady Stein from Northwestern Medicine explains gene mutations related to MPNs and MPN diagnosis. He shares which treatments tend to be effe...
by:patientpower | 111 views

Top Tags



Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)